                         SEQUENCE LISTING

<110>  Magenta Therapeutics Inc
 
<120>  Compositions and Methods for the Expansion of Hematopoietic Stem 
       and Progenitor Cells

<130>  MGTX-003/001WO

<140>  PCT/US2018/058553
<141>  2018-10-31

<150>  62/579,803
<151>  2017-10-31

<150>  62/596,676
<151>  2017-12-08

<150>  62/613,383
<151>  2018-01-03

<150>  62/625,917
<151>  2018-02-02

<150>  62/634,638
<151>  2018-02-23

<150>  62/747,068
<151>  2018-10-17

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  73
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Ala Pro Leu Ala Thr Glu Leu Arg Cys Gln Cys Leu Gln Thr Leu Gln 
1               5                   10                  15      


Gly Ile His Leu Lys Asn Ile Gln Ser Val Lys Val Lys Ser Pro Gly 
            20                  25                  30          


Pro His Cys Ala Gln Thr Glu Val Ile Ala Thr Leu Lys Asn Gly Gln 
        35                  40                  45              


Lys Ala Cys Leu Asn Pro Ala Ser Pro Met Val Lys Lys Ile Ile Glu 
    50                  55                  60                  


Lys Met Leu Lys Asn Gly Lys Ser Asn 
65                  70              


<210>  2
<211>  69
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Thr Glu Leu Arg Cys Gln Cys Leu Gln Thr Leu Gln Gly Ile His Leu 
1               5                   10                  15      


Lys Asn Ile Gln Ser Val Lys Val Lys Ser Pro Gly Pro His Cys Ala 
            20                  25                  30          


Gln Thr Glu Val Ile Ala Thr Leu Lys Asn Gly Gln Lys Ala Cys Leu 
        35                  40                  45              


Asn Pro Ala Ser Pro Met Val Lys Lys Ile Ile Glu Lys Met Leu Lys 
    50                  55                  60                  


Asn Gly Lys Ser Asn 
65                  


<210>  3
<211>  73
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Ala Pro Leu Ala Thr Glu Leu Arg Cys Gln Cys Leu Gln Thr Leu Gln 
1               5                   10                  15      


Gly Ile His Leu Lys Asn Ile Gln Ser Val Lys Val Lys Ser Pro Gly 
            20                  25                  30          


Pro His Cys Ala Gln Thr Glu Val Ile Ala Thr Leu Lys Asn Gly Gln 
        35                  40                  45              


Lys Ala Cys Leu Asn Pro Ala Ser Pro Met Val Lys Lys Ile Ile Glu 
    50                  55                  60                  


Lys Met Leu Lys Asp Gly Lys Ser Asn 
65                  70              


<210>  4
<211>  69
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Thr Glu Leu Arg Cys Gln Cys Leu Gln Thr Leu Gln Gly Ile His Leu 
1               5                   10                  15      


Lys Asn Ile Gln Ser Val Lys Val Lys Ser Pro Gly Pro His Cys Ala 
            20                  25                  30          


Gln Thr Glu Val Ile Ala Thr Leu Lys Asn Gly Gln Lys Ala Cys Leu 
        35                  40                  45              


Asn Pro Ala Ser Pro Met Val Lys Lys Ile Ile Glu Lys Met Leu Lys 
    50                  55                  60                  


Asp Gly Lys Ser Asn 
65                  


